Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmmerson Regulatory News (EML)

Share Price Information for Emmerson (EML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.10
Bid: 1.90
Ask: 2.00
Change: 0.00 (0.00%)
Spread: 0.10 (5.263%)
Open: 1.95
High: 1.95
Low: 1.95
Prev. Close: 1.95
EML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Replacement for Grant of Share Options

6 Aug 2020 11:45

RNS Number : 3880V
Emmerson PLC
06 August 2020
 

 

The following amendments have been made to the Grant of Share Options announcement released on 5 August 2020 at 16.10 under RNS No 2730V.

 

The exercise prices should read £0.001, £0.05, £0.06, £0.07 and £0.10.

 

All other details remain unchanged. The full amended text is shown below.

 

 

Emmerson Plc / Ticker: EML / Index: LSE / Sector: Mining

6 August 2020

Emmerson Plc ("Emmerson" or the "Company") 

Grant of Share Options

 

Emmerson Plc, the Moroccan focused potash development company, announces the grant of 55,000,000 (55 million) options to subscribe for new ordinary shares in the Company (the "New Options") to certain directors and senior management of the Company with effect from 1 August 2020 (the "Grant Date").

 

Details of the Options

Director / Senior Management

New Options

Vesting Dates

Total options held

Mr Graham Clarke

17,500,000

· 500,000 Options on the first anniversary of the Grant Date at a price of £0.001 per ordinary share;

· 1,000,000 Options on the first anniversary of the Grant Date at a price of £0.05 per ordinary share;

· 2,000,000 Options on the first anniversary of the Grant Date at a price of £0.07 per ordinary share;

· 3,333,333 Options on the first anniversary of the Grant Date at a price of £0.10 per ordinary share.

 

· 1,000,000 Options on the second anniversary of the Grant Date at a price of £0.001 per ordinary share;

· 1,000,000 Options on the second anniversary of the Grant Date at a price of £0.05 per ordinary share;

· 2,000,000 Options on the second anniversary of the Grant Date at a price of £0.07 per ordinary share;

· 3,333,333 Options on the second anniversary of the Grant Date at a price of £0.10 per ordinary share.

 

· 3,333,334 Options on the third anniversary of the Grant Date at a price of £0.10 per ordinary share.

17,500,000

Mr Said Hamdioui

3,500,000

· 750,000 Options on the Grant Date at a price of £0.06 per ordinary share;

· 1,000,000 on the Grant Date at a price of £0.10 per ordinary share;

· 750,000 Options on the first anniversary of the Grant Date at a price of £0.06 per ordinary share; and

· 1,000,000 Options on the first anniversary of the Grant Date at a price of £0.10 per ordinary share;

9,500,000

Mr Phil Cleggett

9,000,000

· 2,500,000 Options on the Grant Date at a price of £0.06 per ordinary share

· 2,000,000 Options on the Grant Date at a price of £0.10 per ordinary share

· 2,500,000 Options on the first anniversary of the Grant Date at a price of £0.06 per ordinary share

· 2,000,000 Options on the first anniversary of the Grant Date at a price of £0.10 per ordinary share

14,000,000

Mr Hayden Locke

10,000,000

· One quarter of the Options on the Grant Date at a price of £0.06 per ordinary share;

· one quarter of the Options on the Grant Date at a price of £0.10 per ordinary share;

· one quarter of the Options on the first anniversary of the Grant Date at a price of £0.06 per ordinary share; and

· one quarter of the Options on the first anniversary of the Grant Date at a price of £0.10 per ordinary share.

22,000,000

Mr Mark Connelly

5,000,000

8,000,000

Mr Robert Wrixon

5,000,000

 11,000,000

Mr Ed McDermot

5,000,000

 11,000,000

 

 

 

**ENDS**

 

 

For further information, please visit www.emmersonplc.com, follow us on Twitter (@emmerson_plc), or contact: 

Hayden Locke

Emmerson Plc

Tel: +44 (0) 207 236 1177

Edward McDermott

 

Damon Heath

Shard Capital Partners

Tel: +44 (0) 20 7186 9950

Isabella Pierre

Isabel de Salis

Megan Dennison

St Brides Partners Ltd

Financial PR/IR

Tel: +44 (0) 20 7236 1177

 

Notes to Editors

Emmerson's primary focus is on developing the Khemisset Potash Project located in Northern Morocco. The project has a large JORC Resource Estimate (2012) of 311.4Mt @ 10.2% K2O and significant exploration potential with an accelerated development pathway targeting a low capex, high margin mine. Khemisset is perfectly located to capitalise on the expected growth of African fertiliser consumption whilst also being located on the doorstep of European markets. This unique positioning means the project will receive a premium netback price compared to existing potash producers. The need to feed the world's rapidly increasing population is driving demand for potash and Emmerson is well placed to benefit from the opportunities this presents. 

 

 

1. 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

1. Graham Clarke

2. Said Hamdioui

3. Hayden Locke

4. Phil Cleggett

5. Mark Connelly

6. Robert Wrixon

7. Ed McDermott

 

2. 

Reason for the notification

a)

Position/status:

1. CEO

2. Advisor

3. Executive Director

4. Head of Corporate Development

5. Chairman

6. Executive Director

7. Non-Executive Director

b)

Initial notification/Amendment:

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Emmerson Plc

b)

LEI:

213800WAVVOPS85N2205

 

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of NPV

 

 

ISIN: IM00BDHDTX83 

 

b)

Nature of the transaction:

Grant of Options

c)

Price(s) and volume(s):

 

Volume Price (£)

 

1. Graham Clarke

i) 500,000 0.001

ii) 1,000,000 0.05

iii) 2,000,000 0.07

iv) 3,333,333 0.10

v) 1,000,000 0.001

vi) 1,000,000 0.05

vii) 2,000,000 0.07

viii) 3,333,333 0.10

ix) 3.333.334 0.10

 

2. Said Hamdioui

i) 750,000 0.06

ii) 1,000,000 0.10

iii) 750,000 0.06

iv) 1,000,000 0.10

 

3. Hayden Locke

i) 2,500,000 0.06

ii) 2,500,000 0.10

iii) 2,500,000 0.06

iv) 2,500,000 0.10

 

4. Phil Cleggett

i) 2,500,000 0.06

ii) 2,000,000 0.10

iii) 2,500,000 0.06

iv) 2,000,000 0.10

 

5. Mark Connelly

i) 1,250,000 0.06

ii) 1,250,000 0.10

iii) 1,250,000 0.06

iv) 1,250,000 0.10

 

6. Robert Wrixon

i) 1,250,000 0.06

ii) 1,250,000 0.10

iii) 1,250,000 0.06

iv) 1,250,000 0.10

 

7. Ed McDermott

i) 1,250,000 0.06

ii) 1,250,000 0.10

iii) 1,250,000 0.06

iv) 1,250,000 0.10

d)

Aggregated information:

Aggregated volume:

Price:

 

n/a 

e)

Date of the transaction:

1 August 2020

f)

Place of the transaction:

Outside a trading Venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUNORRRKUWRAR
Date   Source Headline
31st May 202410:56 amRNSGrant of Share Options and PDMR dealing
31st May 20247:00 amRNSNotice of AGM and Posting of Annual Report
24th May 20247:00 amRNS2023 Financial Results
22nd Apr 202411:47 amRNSTR-1: Notification of major holdings
8th Apr 20244:45 pmRNSResults of Oversubscribed REX Retail Offer
8th Apr 20247:01 amRNSREX Retail Offer
8th Apr 20247:00 amRNSQ1 Update, Equity Placing and Retail Offer
11th Mar 20247:00 amRNSCommittee Upholds Environmental Approval Referral
1st Feb 20247:00 amRNSScoping Study on Breakthrough New Processing Route
8th Jan 20247:00 amRNSQ4 Update
21st Dec 20237:00 amRNSExtension of Mandated Lead Arrangers
26th Sep 20237:00 amRNSInterim Results for the six months to 30 June 2023
21st Sep 20237:00 amRNSQ3 2023 and Financing update
11th Sep 202311:38 amRNSMorocco Statement
11th Jul 202311:57 amRNSDirector/PDMR Shareholding
10th Jul 20234:30 pmRNSDirector/PDMR Shareholding
6th Jul 20232:49 pmRNSDirector/PDMR Shareholding
6th Jul 20237:00 amRNSQ2 Update
6th Jun 20237:00 amRNSExercise & Allotment of Shares
31st May 202312:01 pmRNSResult of AGM
5th May 20237:00 amRNSNotice of AGM and Posting of Annual Report
13th Apr 20237:00 amRNS2022 Financial Results and Q1 Update
14th Feb 20237:00 amRNSMandated Lead Arrangers Appointed for Financing
9th Jan 20237:00 amRNSQ4 Update
3rd Jan 20237:00 amRNSAppointment of Liberum as Nominated Advisor
21st Nov 20227:00 amRNSPotash and Salt Offtake MOUs
27th Sep 20227:00 amRNSDirector/PDMR Shareholding
26th Sep 20221:45 pmRNSResults of REX Retail Offer & Total Voting Rights
26th Sep 20227:02 amRNSREX Retail Offer
26th Sep 20227:01 amRNSRenewal of Strategic Investment & Equity Placing
26th Sep 20227:00 amRNSInterim Results for the six months to 30 June 2022
16th Aug 20224:18 pmRNSExercise of Options & Director/PDMR Shareholding
22nd Jul 20229:00 amRNSShare Options Scheme & Director Shareholdings
19th Jul 20225:05 pmRNSReplacement: Director/PDMR Shareholding
18th Jul 20224:00 pmRNSDirector/PDMR Shareholding
11th Jul 20227:00 amRNSQ2 Activities Update
7th Jul 202212:30 pmRNSResult of AGM
20th Jun 20227:00 amRNSExercise of Warrants and Issue of Shares
13th Jun 20227:00 amRNSNotice of AGM and Posting of Annual Report
31st May 20227:00 amRNSAudited Results for the year ended 31 Dec 2021
31st Mar 20227:00 amRNSQ1 Activities Update
15th Mar 20227:00 amRNSGrant of Share Options
21st Feb 20227:00 amRNSAppointment of Chief Financial Officer
16th Feb 20227:00 amRNSAppointment of Corporate Broker
27th Jan 20227:00 amRNSBasic Engineering Packages Awarded to Reminex S.A
25th Jan 20221:00 pmRNSPart Exercise of Options and Issue of Shares
31st Dec 20217:00 amRNSEnd of Year Newsletter
6th Dec 202112:45 pmRNSResult of AGM
6th Dec 202112:31 pmRNSResult of General Meeting
2nd Dec 20217:00 amRNSOperational Update: Khemisset Potash Project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.